SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-100682
Filing Date
2019-04-08
Accepted
2019-04-08 16:02:03
Documents
5
Period of Report
2019-05-23
Effectiveness Date
2019-04-08

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d723961ddef14a.htm DEF 14A 414111
2 GRAPHIC g723961g34y39.jpg GRAPHIC 28870
3 GRAPHIC g723961g62r17.jpg GRAPHIC 30086
4 GRAPHIC g723961g80k82.jpg GRAPHIC 193515
5 GRAPHIC g723961g98a61.jpg GRAPHIC 160714
  Complete submission text file 0001193125-19-100682.txt   984470
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35420 | Film No.: 19737488
SIC: 2834 Pharmaceutical Preparations